BR112012002117A2 - composições poliméricas modificadas de ácido hialurônico e métodos relacionados. - Google Patents
composições poliméricas modificadas de ácido hialurônico e métodos relacionados.Info
- Publication number
- BR112012002117A2 BR112012002117A2 BR112012002117A BR112012002117A BR112012002117A2 BR 112012002117 A2 BR112012002117 A2 BR 112012002117A2 BR 112012002117 A BR112012002117 A BR 112012002117A BR 112012002117 A BR112012002117 A BR 112012002117A BR 112012002117 A2 BR112012002117 A2 BR 112012002117A2
- Authority
- BR
- Brazil
- Prior art keywords
- hyaluronic acid
- related methods
- polymeric compositions
- modified polymeric
- modified
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23007409P | 2009-07-30 | 2009-07-30 | |
| US31195310P | 2010-03-09 | 2010-03-09 | |
| PCT/US2010/043108 WO2011014432A1 (en) | 2009-07-30 | 2010-07-23 | Modified hyaluronic acid polymer compositions and related methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012002117A2 true BR112012002117A2 (pt) | 2019-09-24 |
Family
ID=42932126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012002117A BR112012002117A2 (pt) | 2009-07-30 | 2010-07-23 | composições poliméricas modificadas de ácido hialurônico e métodos relacionados. |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US7829118B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2459239A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5683587B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101551681B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102573941B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010276574B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012002117A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2769470A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2012000243A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL217750B (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012001204A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2539395C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG178146A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011014432A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201200727B (cg-RX-API-DMAC7.html) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012002117A2 (pt) | 2009-07-30 | 2019-09-24 | Carbylan Biosurgery Inc | composições poliméricas modificadas de ácido hialurônico e métodos relacionados. |
| CZ2009836A3 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace |
| CZ302503B6 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace |
| CA2805008C (en) * | 2010-07-12 | 2015-05-12 | Shin Poong Pharmaceutical Co., Ltd. | Filler composition for tissue augmentation comprising a hydrogel of hyaluronic acid cross-linked with alkylene diamine |
| FR2968306B1 (fr) * | 2010-12-06 | 2014-02-28 | Teoxane | Procede de preparation d'un gel reticule |
| US20120142628A1 (en) * | 2010-12-07 | 2012-06-07 | Allergan, Inc. | Methods for treating crepitus |
| GB201101429D0 (en) * | 2011-01-27 | 2011-03-16 | Biocompatibles Uk Ltd | Drug delivery system |
| DK2699274T3 (en) * | 2011-04-20 | 2015-06-15 | Carbylan Therapeutics Inc | In situ gelling formations |
| CZ304072B6 (cs) * | 2011-04-26 | 2013-09-25 | Contipro Biotech S.R.O. | Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití |
| CA2838059C (en) * | 2011-06-03 | 2020-08-25 | Maguire Abbey, Llc | Method, composition, and articles for improving joint lubrication |
| WO2012171335A1 (en) * | 2011-06-16 | 2012-12-20 | The Hong Kong University Of Science And Technology | Multi-vinylsulfone containing molecule |
| TWI561535B (en) | 2011-10-06 | 2016-12-11 | Bvw Holding Ag | Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption |
| US20130108550A1 (en) | 2011-10-26 | 2013-05-02 | Abbott Cardiovasculr Systems, Inc. | Bioabsorbable Co-Filler for Cerebrovascular Aneurysms |
| WO2013078770A1 (en) * | 2011-12-02 | 2013-06-06 | The Hong Kong University Of Science And Technology | Injectable gelling material |
| CZ303879B6 (cs) | 2012-02-28 | 2013-06-05 | Contipro Biotech S.R.O. | Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití |
| CZ304512B6 (cs) | 2012-08-08 | 2014-06-11 | Contipro Biotech S.R.O. | Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití |
| CZ304654B6 (cs) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
| HK1214618A1 (zh) | 2013-01-11 | 2016-07-29 | Carbylan Therapeutics, Inc. | 含有透明質酸的穩定化組合物 |
| JP6215354B2 (ja) * | 2013-01-23 | 2017-10-18 | セムヌール ファーマシューティカルズ, インコーポレイテッド | 不溶性コルチコステロイドおよび可溶性コルチコステロイドを含む医薬処方物 |
| JP6781220B2 (ja) * | 2013-02-04 | 2020-11-04 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | 基板用コーティング |
| RU2698315C2 (ru) * | 2013-02-04 | 2019-08-26 | В.Л. Гор Энд Ассошиейтс, Инк. | Покрытие для подложки |
| US9511119B2 (en) * | 2013-03-15 | 2016-12-06 | NuTech Spine, Inc. | Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same |
| US9844597B2 (en) | 2013-04-18 | 2017-12-19 | The Hong Kong University Of Science And Technology | Biocompatible in situ hydrogel |
| RU2640865C2 (ru) * | 2013-06-28 | 2018-01-12 | Гальдерма С.А. | Способ производства формованного продукта из поперечно-сшитой гиалуроновой кислоты |
| WO2015053282A1 (ja) * | 2013-10-08 | 2015-04-16 | キユーピー株式会社 | カルボキシメチル基含有修飾ヒアルロン酸および/またはその塩の架橋物およびその製造方法 |
| CN105658674B (zh) * | 2013-10-08 | 2019-04-09 | 丘比株式会社 | 含有羧甲基的修饰透明质酸和/或其盐和/或其制造方法 |
| WO2015053281A1 (ja) * | 2013-10-08 | 2015-04-16 | キユーピー株式会社 | カルボキシメチル基含有修飾ヒアルロン酸および/またはその塩の架橋物およびその製造方法 |
| WO2015134906A1 (en) * | 2014-03-07 | 2015-09-11 | Endologix, Inc. | Forming hydrogels and materials therefor |
| US9895394B2 (en) * | 2014-03-10 | 2018-02-20 | Kai-shun Christopher LEUNG | Induction of chronic elevation of intraocular pressure with vinysulfonated hyaluronic acid (HA-VS) and thiolated hyaluronic acid (HA-SH)hydrogel |
| CZ2014150A3 (cs) | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití |
| CZ2014451A3 (cs) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
| KR20170070008A (ko) | 2014-08-15 | 2017-06-21 | 더 존스 홉킨스 유니버시티 | 조직 복원용 복합 재료 |
| CZ309295B6 (cs) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití |
| CZ2015398A3 (cs) | 2015-06-15 | 2017-02-08 | Contipro A.S. | Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin |
| CZ306662B6 (cs) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití |
| EP3320028A1 (en) * | 2015-09-01 | 2018-05-16 | Merz Pharma GmbH & Co. KGaA | Method of making a cross-linked polymer gel and device for performing the method |
| WO2017042301A1 (en) * | 2015-09-09 | 2017-03-16 | ETH Zürich | Injectable macroporous hydrogels |
| CN108697804B (zh) * | 2015-10-05 | 2022-11-15 | 德克萨斯州立大学董事会 | 用于软骨损伤的检测和治疗的微米和纳米装置 |
| CN105606602A (zh) * | 2015-12-22 | 2016-05-25 | 上海景峰制药有限公司 | 一种测定交联透明质酸钠凝胶中二巯基聚乙二醇残留的方法 |
| TWI727014B (zh) * | 2016-03-24 | 2021-05-11 | 德商梅茲製藥有限兩合公司 | 修飾透明質酸與其製造方法及其用途 |
| CZ308106B6 (cs) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití |
| KR20180027126A (ko) | 2016-09-06 | 2018-03-14 | (주)한국비엠아이 | 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물 |
| EP4253956A3 (en) * | 2016-10-14 | 2023-12-06 | Wake Forest University Health Sciences | Multi-organ "body on a chip" apparatus utilizing a common media |
| WO2018136205A1 (en) * | 2016-12-29 | 2018-07-26 | Tempo Therapeutics, Inc. | Methods and systems for treating a site of a medical implant |
| BR112019017795B1 (pt) | 2017-02-28 | 2022-12-06 | Cg Bio Co., Ltd. | Composição para injeção dérmica |
| EP3590546B1 (en) * | 2017-02-28 | 2024-08-21 | CG Bio Co., Ltd. | Composition for skin injection |
| WO2018159982A1 (ko) * | 2017-02-28 | 2018-09-07 | (주)시지바이오 | 피부 주입용 조성물 |
| US20180250225A1 (en) * | 2017-03-01 | 2018-09-06 | Church & Dwight Co., Inc. | Gummy composition with improved stability |
| EP3600442A1 (en) * | 2017-03-22 | 2020-02-05 | Genentech, Inc. | Optimized antibody compositions for treatment of ocular disorders |
| US11419941B2 (en) | 2017-05-30 | 2022-08-23 | Brenda K. Mann | Vaginal hydrogel |
| JP7854781B2 (ja) * | 2017-09-01 | 2026-05-07 | ピーエムアイディージー・エルエルシー | 官能基化および架橋ポリマー |
| US12029753B2 (en) | 2017-09-19 | 2024-07-09 | The Hong Kong University Of Science And Technology | Biocompatible material and methods for making and using thereof |
| US20190240335A1 (en) * | 2018-02-07 | 2019-08-08 | Promedon S.A. | Biocompatible Hydrogel Compositions |
| US10959945B2 (en) | 2018-03-21 | 2021-03-30 | Marina Lee Gerton | Vaginal hydrogel for delivery of therapeutics |
| EP3790602A1 (en) | 2018-05-09 | 2021-03-17 | The Johns Hopkins University | Nanofiber-hydrogel composites for cell and tissue delivery |
| ES3060255T3 (en) | 2018-05-09 | 2026-03-25 | Univ Johns Hopkins | Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration |
| CN112702992A (zh) * | 2018-07-20 | 2021-04-23 | 香港科技大学 | 用于靶试剂的受控释放的组合物和方法 |
| CN109045354B (zh) * | 2018-07-26 | 2020-12-08 | 华中科技大学 | 一种用于骨-软骨综合修复的原位成型可注射水凝胶 |
| EP3852725A4 (en) * | 2018-09-20 | 2022-08-03 | The Hong Kong University of Science and Technology | EYE DROP COMPOSITIONS |
| CN109223708B (zh) * | 2018-10-24 | 2021-07-20 | 上海景峰制药有限公司 | 一种交联玻璃酸钠的抗肿瘤药物组合物及其制备方法和应用 |
| EP3956367A1 (en) * | 2019-04-19 | 2022-02-23 | Jointherapeutics S.r.l. | Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states |
| KR102176486B1 (ko) * | 2019-06-14 | 2020-11-10 | 동국대학교 산학협력단 | 히알루론산 기반의 안과용 약물전달체의 제조방법 |
| CN111187429B (zh) * | 2019-06-18 | 2020-08-14 | 吾奇生物医疗科技(镇江)有限公司 | 双交联胶原水凝胶材料、其制备方法与应用 |
| WO2020264392A1 (en) * | 2019-06-26 | 2020-12-30 | Lacerta Technologies Inc. | Cross-linked hyaluronic acid hydrogels comprising proteins |
| CN110204746B (zh) * | 2019-06-28 | 2022-03-08 | 浙江科技学院 | 一种交联透明质酸钠凝胶的制备方法 |
| EP4090317A4 (en) * | 2020-01-16 | 2024-02-21 | The Hong Kong University of Science and Technology | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF A TARGET AGENT |
| JP2023522079A (ja) * | 2020-04-17 | 2023-05-26 | ブレンダン パトリック パーセル | ヒアルロン酸組成物の制御放出 |
| US20230173074A1 (en) * | 2020-04-23 | 2023-06-08 | Pleryon Therapeutics (Shenzhen) Limited | Biocompatible material and methods for making and using the same |
| WO2022120097A1 (en) * | 2020-12-03 | 2022-06-09 | Pmidg, Llc | Functionalized and crosslinked polymers |
| CN114276563B (zh) * | 2020-12-14 | 2023-02-24 | 南京工业大学 | 医用水凝胶的制备方法、水凝胶及敷料 |
| WO2022165416A1 (en) * | 2021-02-01 | 2022-08-04 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for making and using hybrid network hydrogels |
| KR102888000B1 (ko) * | 2021-10-25 | 2025-11-24 | 바이오플러스 주식회사 | 가교 히알루론산을 포함하는 가슴 보형물 및 이의 제조방법 |
| DE102021212812A1 (de) * | 2021-11-15 | 2023-05-17 | Bauerfeind Ag | Entzündungshemmendes viskosupplementierendes Mittel enthaltend Hyaluronsäure |
| ES2997963T3 (en) * | 2021-11-16 | 2025-02-18 | Pompadour Iberica S A | A beverage composition with controlled effervescence for infusion in a cold liquid |
| CN116919983A (zh) * | 2022-04-07 | 2023-10-24 | 北京瑞熙天成生物科技有限公司 | 一种用于治疗关节炎的基于官能化透明质酸或其钠盐的药物组合及其应用 |
| CN116919982A (zh) * | 2022-04-07 | 2023-10-24 | 北京瑞熙天成生物科技有限公司 | 一种用于治疗关节炎的药物组合物及其应用 |
| CN115364044B (zh) * | 2022-06-17 | 2024-07-09 | 浙江大学医学院附属第一医院 | 一种药物组合物及其制备方法和用途 |
| WO2024030437A1 (en) * | 2022-08-01 | 2024-02-08 | Pmidg, Llc | Functionalized and crosslinked polymer methods and compositions |
| KR20260009801A (ko) * | 2023-02-15 | 2026-01-20 | 라이프스프라웃, 인크. | 콜라겐-히드로겔 복합체 |
| CN121013705A (zh) * | 2023-02-15 | 2025-11-25 | 生命萌芽公司 | 改性的交联聚合物 |
| FI20245016A1 (en) * | 2024-01-11 | 2025-07-12 | Fysioline Oy | INJECTABLE COMPOSITION FOR CONTROLLED MEDICINE ADMINISTRATION |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128326A (en) | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| US4582865A (en) | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| DK130991D0 (da) | 1991-07-04 | 1991-07-04 | Immunodex K S | Polymere konjugater |
| WO1997022371A1 (en) | 1995-12-18 | 1997-06-26 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
| US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| PT939086E (pt) | 1998-02-27 | 2004-07-30 | Stichting Hippomedics | Processo para produzir o acido hialuronico reticulado |
| US6056970A (en) | 1998-05-07 | 2000-05-02 | Genzyme Corporation | Compositions comprising hemostatic compounds and bioabsorbable polymers |
| US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| US6521223B1 (en) * | 2000-02-14 | 2003-02-18 | Genzyme Corporation | Single phase gels for the prevention of adhesions |
| WO2002009792A1 (en) * | 2000-07-28 | 2002-02-07 | Anika Therapeutics, Inc. | Bioabsorbable composites of derivatized hyaluronic acid |
| WO2002068383A2 (en) * | 2001-02-22 | 2002-09-06 | Anika Therapeutics, Inc. | Thiol-modified hyaluronan |
| WO2003096015A1 (en) | 2002-05-08 | 2003-11-20 | Matsushita Electric Industrial Co., Ltd. | Biomolecular substrate, method of testing or diagnosis with use thereof and apparatus therefor |
| US7034127B2 (en) * | 2002-07-02 | 2006-04-25 | Genzyme Corporation | Hydrophilic biopolymer-drug conjugates, their preparation and use |
| US6802377B2 (en) | 2002-08-28 | 2004-10-12 | Mark S. Foltz | Hammer mounting apparatus |
| WO2004046200A1 (ja) | 2002-11-21 | 2004-06-03 | Chugai Seiyaku Kabushiki Kaisha | 薬物徐放担体 |
| US20050056608A1 (en) | 2003-09-15 | 2005-03-17 | Nesin Milton Scott | Bottle insert for storing and dispensing baby formula |
| US20050282747A1 (en) * | 2003-10-01 | 2005-12-22 | The Research Foundation Of State University Of New York At Stony Brook | Methods and compositions for wound healing |
| WO2005054301A1 (ja) | 2003-11-14 | 2005-06-16 | Chugai Seiyaku Kabushiki Kaisha | 架橋多糖微粒子およびその製造方法 |
| EP1694712A1 (en) | 2003-12-04 | 2006-08-30 | University of Utah Research Foundation | Modified macromolecules and methods of making and using thereof |
| KR20060130606A (ko) | 2003-12-12 | 2006-12-19 | 추가이 세이야쿠 가부시키가이샤 | 세포사 유도제 |
| BRPI0418309B8 (pt) * | 2003-12-30 | 2021-05-25 | Genzyme Corp | "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis". |
| US8524213B2 (en) | 2003-12-30 | 2013-09-03 | Genzyme Corporation | Polymeric materials, their preparation and use |
| WO2006028110A1 (ja) | 2004-09-07 | 2006-03-16 | Chugai Seiyaku Kabushiki Kaisha | 水溶性ヒアルロン酸修飾物の製造方法 |
| JP4875988B2 (ja) * | 2004-11-15 | 2012-02-15 | 株式会社 資生堂 | 架橋ヒアルロン酸ゲルの製造方法 |
| EP1817347B1 (en) | 2004-11-24 | 2017-05-17 | Albumedix A/S | Method of cross-linking hyaluronic acid with divinylsulfone |
| US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
| EP1994062B1 (en) | 2006-03-02 | 2009-07-15 | Novozymes Biopolymer A/S | Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| EP1871038B1 (en) | 2006-06-23 | 2010-06-02 | Nippon Office Automation Co., Ltd. | Network protocol and session analyser |
| WO2008008857A2 (en) | 2006-07-11 | 2008-01-17 | University Of Utah Research Foundation | Thiolated macromolecules and methods of making and using thereof |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | 巴克斯特國際公司 | 快速作用之乾密封膠及其使用和製造方法 |
| CN101200504B (zh) | 2006-12-11 | 2010-05-12 | 上海百瑞吉生物医药有限公司 | 高分子巯基化改性衍生物及其交联材料 |
| US20110077737A1 (en) | 2007-07-30 | 2011-03-31 | Allergan, Inc. | Tunably Crosslinked Polysaccharide Compositions |
| US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
| BR112012002117A2 (pt) | 2009-07-30 | 2019-09-24 | Carbylan Biosurgery Inc | composições poliméricas modificadas de ácido hialurônico e métodos relacionados. |
| US8273725B2 (en) | 2009-09-10 | 2012-09-25 | Genzyme Corporation | Stable hyaluronan/steroid formulation |
-
2010
- 2010-07-23 BR BR112012002117A patent/BR112012002117A2/pt not_active IP Right Cessation
- 2010-07-23 AU AU2010276574A patent/AU2010276574B2/en not_active Ceased
- 2010-07-23 CN CN201080044014.3A patent/CN102573941B/zh not_active Expired - Fee Related
- 2010-07-23 US US12/842,762 patent/US7829118B1/en not_active Expired - Fee Related
- 2010-07-23 EP EP10738103A patent/EP2459239A1/en not_active Withdrawn
- 2010-07-23 RU RU2012107283/15A patent/RU2539395C2/ru not_active IP Right Cessation
- 2010-07-23 SG SG2012006227A patent/SG178146A1/en unknown
- 2010-07-23 US US13/387,682 patent/US8790702B2/en not_active Expired - Fee Related
- 2010-07-23 CA CA2769470A patent/CA2769470A1/en not_active Abandoned
- 2010-07-23 JP JP2012522921A patent/JP5683587B2/ja not_active Expired - Fee Related
- 2010-07-23 MX MX2012001204A patent/MX2012001204A/es active IP Right Grant
- 2010-07-23 KR KR1020127005345A patent/KR101551681B1/ko not_active Expired - Fee Related
- 2010-07-23 WO PCT/US2010/043108 patent/WO2011014432A1/en not_active Ceased
-
2012
- 2012-01-26 IL IL217750A patent/IL217750B/en not_active IP Right Cessation
- 2012-01-30 CL CL2012000243A patent/CL2012000243A1/es unknown
- 2012-01-30 ZA ZA2012/00727A patent/ZA201200727B/en unknown
-
2014
- 2014-07-16 US US14/333,426 patent/US9192678B2/en not_active Expired - Fee Related
-
2015
- 2015-10-30 US US14/929,115 patent/US9446136B2/en not_active Expired - Fee Related
-
2016
- 2016-09-13 US US15/264,550 patent/US9980977B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20160193342A1 (en) | 2016-07-07 |
| IL217750A0 (en) | 2012-03-29 |
| SG178146A1 (en) | 2012-03-29 |
| WO2011014432A1 (en) | 2011-02-03 |
| JP2013501091A (ja) | 2013-01-10 |
| US20140328926A1 (en) | 2014-11-06 |
| US9192678B2 (en) | 2015-11-24 |
| US9446136B2 (en) | 2016-09-20 |
| US7829118B1 (en) | 2010-11-09 |
| RU2539395C2 (ru) | 2015-01-20 |
| CL2012000243A1 (es) | 2012-12-21 |
| RU2012107283A (ru) | 2013-09-10 |
| US20170224708A1 (en) | 2017-08-10 |
| JP5683587B2 (ja) | 2015-03-11 |
| CA2769470A1 (en) | 2011-02-03 |
| US8790702B2 (en) | 2014-07-29 |
| AU2010276574B2 (en) | 2015-08-20 |
| IL217750B (en) | 2018-01-31 |
| AU2010276574A1 (en) | 2012-02-23 |
| CN102573941A (zh) | 2012-07-11 |
| ZA201200727B (en) | 2013-05-29 |
| CN102573941B (zh) | 2014-10-29 |
| KR20120052371A (ko) | 2012-05-23 |
| US20120128741A1 (en) | 2012-05-24 |
| EP2459239A1 (en) | 2012-06-06 |
| KR101551681B1 (ko) | 2015-09-09 |
| MX2012001204A (es) | 2012-08-03 |
| US9980977B2 (en) | 2018-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201200727B (en) | Modified hyaluronic acid polymer compositions and related methods | |
| EP2473555A4 (en) | POLYMER COMPOSITIONS | |
| EP2515946A4 (en) | NANOCONJUGATE AND NANOCONJUGATE FORMULATIONS | |
| EP2513023A4 (en) | COMPOSITIONS OF CIS-1,1,1,4,4,4-HEXAFLUOR-2-BUTENE AND ITS USES | |
| BR112012004108A2 (pt) | composições de poliidroxialcanoato endurecidas | |
| HRP20160737T1 (hr) | Anti-her3-protutijela i njihove uporabe | |
| UY33146A (es) | Proceso de biodegradacion y composicion | |
| FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
| DK3569256T3 (da) | Stabiliserede fibronectin-domænesammensætninger, fremgangsmåder og anvendelser | |
| PL2424372T3 (pl) | Kompozycje przeciwdrobnoustrojowe i powiązane sposoby zastosowania | |
| BRPI1013222A2 (pt) | composições de mirceno polimérico | |
| EP2403441A4 (en) | STENT | |
| BR112012013954A2 (pt) | derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico e método de modificação do derivado de ácido hialurônico | |
| BR112012013955A2 (pt) | método de preparação de um derivado oxidado de ácido hialurônico e método de modificação do derivado de ácido hialurônico | |
| PL2356462T3 (pl) | Kompozycje anty-CXCR1 oraz sposoby | |
| EP2476717A4 (en) | POLYAMIDE AND POLYAMIDE COMPOSITION | |
| BRPI1006229A2 (pt) | composição incluindo uma quantidade suficiente de curcumina | |
| EP2471889A4 (en) | METAL COMPLEX COMPOSITION AND COMPLEX POLYMER | |
| EP2412756A4 (en) | Curable composition | |
| BR112013014204A2 (pt) | composições de sucops espumantes | |
| EP2428552A4 (en) | BIODEGRADABLE LUBRICANT COMPOSITION | |
| BRPI1009446A2 (pt) | Composições compreendendo monatina e cálcio | |
| DK2453858T3 (da) | Fremgangsmåde | |
| EP2479211A4 (en) | FLUOR RUBBER COMPOSITION | |
| DK2431450T3 (da) | Bionedbrydelig smøremiddelsammensætning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |